ITA Partners extends oncology decision-support offerings with eviti
eviti aligns physician and payer priorities and takes decision support beyond existing pathways approaches with a breakthrough method of ensuring appropriate oncology treatment from the start while streamlining reimbursement
Philadelphia, PA, August 4, 2010 – ITA Partners, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, is extending its decision-support services with the introduction of eviti™. This innovative, breakthrough technology gives oncologists and insurers access to ITA’s independent, non-proprietary oncology treatment library of nearly 1,000 of the most appropriate, proven treatment options covering all modalities for more than 120 cancer types. eviti’s decision-support engine and comprehensive treatment knowledge base automatically align the prescription of quality treatment with each patient’s insurance plan language at the point of prescribing. This transformative technology ensures the very best cancer treatment decision support is available for physicians and patients in any setting; streamlines workflows and reimbursement approval for physicians; and gives payers assurance that they are paying for quality, appropriate care from the start.
“Cancer includes a multitude of different diseases, each with dozens of possible treatment options. One of the biggest challenges for oncologists today is finding time in their increasingly busy schedules to keep up with the latest clinical and therapeutic advances in order to make the best, evidence-based treatment decision for each patient,” said Eduardo Beruff, chief executive officer and president of ITA Partners, Inc. “By providing oncologists with real-time, actionable information at the moment of treatment decision, we can help them to choose from among the best treatment options for each patient in order to improve care, and lower risks and costs.”
Beruff continued, “eviti is unique in that the system helps oncologists select a treatment option that is both evidence-based and compliant with each patient's insurance plan language. Additionally, if the physician chooses a regimen that is outside the patient’s plan language, ITA’s team of oncologists and oncology experts will facilitate a resolution with the insurance company.”
Read more: ITA Partners extends oncology decision-support offerings with eviti
Arlene Forastiere, MD, Joins ITA Partners
Medical risk management company ensures delivery of evidence-based treatment; reduces cost burden in critical illnesses such as cancer and advanced renal disease
July 27, 2009 Philadelphia — ITA Partners, Inc.®, announced today that Arlene A. Forastiere, MD, an internationally recognized expert in cancers of the head, neck, larynx and esophagus, starts Aug. 3 as Senior Vice President, Medical Affairs.
Dr. Forastiere, Professor of Oncology at Johns Hopkins University School of Medicine, has led ITA’s Medical Advisory Board since 2004. This 12-member board includes leading U.S. oncologists whose work helps set standards in cancer treatment.
Currently specializing in oncology and end-stage renal disease, ITA improves medical outcomes for patients and thus delivers quantifiable cost savings for them and for payers. ITA’s medical professionals and patent-pending health information support system ensure treatment meets latest standards; patients receive correct, timely, ongoing care; and patients and their families are prepared to make informed healthcare decisions.
Soon-Shiong Joins Board of ITA Partners
Philadelphia-based ITA Partners delivers ‘transformational’ services for cancer and advanced renal disease patients
Jan. 26, 2009 Philadelphia — ITA Partners, Inc. is pleased to announce that Patrick Soon-Shiong, MD, noted research scientist and visionary in medical information technology, has joined ITA’s Board of Directors.
Currently specializing in oncology and end-stage renal disease, ITA improves medical outcomes for patients and thus delivers quantifiable cost savings for them and for payers. ITA’s medical professionals and patent-pending health information support systems ensure treatment meets latest standards; patients receive correct, timely, ongoing care; and patients and their families are prepared to make informed healthcare decisions.